Thursday, February 21, 2019

MD Update

Know A Good Doctor? We Do.

MD Update

  • Health Topics
    • Audiology
    • Cancer Care
    • Complementary Care
    • Dermatology & Plastic Surgery
    • Heart & Lung
    • Internal Systems
    • Mental Wellness
    • Neurology & Neurosurgery
    • Ophthalmology & ENT/Allergy
    • Orthopedics & Sports Medicine
    • Primary Care & Pediatrics
    • Psychiatry & Mental Health
    • Q&A
    • Women’s Health
  • Healthcare Business
    • Accounting
    • Finance
    • Legal
  • News
  • About Us
  • Get Involved
    • Advertise
    • Contribute
    • Subscribe
  • Archives

popular tamper-resistant technology

Physician Viewpoint 

Is There a Method to This Madness?

March 1, 2014 James Patrick Murphy, MD, MM acetaminophen, addiction, addiction medicine, advantage of a delivery system, APAP, around-the-clock pain, available opioid, Avinza, cause liver failure, effective opioid, extended-release, extended-release drug, extended-release hydrocodone pill, FDA, FDA conspiracy, Focalin XR, hard-copy prescription, hydrocodone, hydrocodone extended-release, hydrocodone-APAP, hydrocodone-APAP combination, hydrocodone-APAP pill, leader 's concern, legitimate worry, long-lasting version, madness, medical lifetime, morphine, new hard-copy prescription, Opana ER, Opioid, opioids, oxymorphone, pain, pain pill, physician, pill, popular tamper-resistant technology, practical purpose, prescribed opioid, real villain, reformulation, Ritalin LA, schedule-three, schedule-three drug, schedule-two, schedule-two drug, short-acting pill form, tamper-resistant, tamper-resistant technology, villain, worry of mass, Zohydro ER

In March 2014, Zohydro ER (hydrocodone extended-release) was introduced to the market. Never in my medical lifetime do I recall

Read more

Search By Specialty

Archives

Contact Gil Dunn (Publisher)

859-309-0720
gdunn@md-update.com
Copyright © 2019 MD Update. All rights reserved.
Theme: ColorMag Pro by ThemeGrill. Powered by WordPress.